In a Q&A, scholars at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School raise important legal and ethical questions about health care delivery and the enactment of extraordinary public health measures in response to the ongoing epidemic.
This month, Harvard Law Professors Jim Greiner and I. Glenn Cohen teamed up with bioethics scholar Holly Fernandez Lynch to author “Overcoming obstacles to experiments in legal practice,” in which the collaborators argue in favor of randomized studies in legal research over the common practice of relying on the expertise and judgment of individuals.
Patients are often subjected to nonconsensual procedures and other mistreatment during the birthing process; Alexa Richardson, a student fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School, is working to bring this situation to light.
Amid rising rates of diabetes and obesity in the nation, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School recently hosted a panel discussion concerning levies—those enacted, those proposed and those failed—on sugary beverages in jurisdictions nationwide.
The General Counsels Roundtable helps influential health law attorneys stay on top of or even ahead of changes in health law and policy. The roundtable connects GC to experts at HLS and the broader university, while also strengthening ties between faculty and legal practice.
This fall, the Harvard Law School Library hosted a series of book talks by Harvard Law School authors on topics ranging from forgiveness in law, transparency in health and fidelity in constitutional practice.
Clinical Professor Robert Greenwald discusses PEPFAR’s impact at home in the United States, policy barriers to "getting to zero," and ways to address the epidemic head-on.
Calls are growing for the U.S. to lift a ban on mitochondrial replacement therapy, or MRT, a procedure developed to enable women who are at risk of passing on rare but devastating diseases to have healthy, biologically related children.
As part of a series called Focal Point, in which the Harvard Gazette asks a range of Harvard faculty members to answer the same question, I. Glenn Cohen explains why we should scrutinize what is and then ponder what should be.
Dalia Deak ’19 is this year’s winner of the individual David Grossman Exemplary Clinical Award, given each year to the student who embodies the pro bono spirit of the late professor and exemplifies putting theory into practice through clinical work.
